MedPath

重庆瑞泊莱制药有限公司

Ownership
-
Established
2012-11-12
Employees
-
Market Cap
-
Website
www.biolandpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Clindamycin Palmitate Hydrochloride

Product Name
盐酸克林霉素棕榈酸酯
Approval Number
国药准字H20173046
Approval Date
Jan 21, 2022
NMPA

Flavoxate Hydrochloride

Product Name
盐酸黄酮哌酯
Approval Number
国药准字H20083221
Approval Date
Mar 18, 2018
NMPA

Povidone Iodine

Product Name
聚维酮碘
Approval Number
国药准字H50021274
Approval Date
Dec 25, 2017
NMPA

Potassium Iodate

Product Name
碘酸钾
Approval Number
国药准字H10880016
Approval Date
Dec 25, 2012
NMPA

Potassium Iodide

Product Name
碘化钾
Approval Number
国药准字H50021273
Approval Date
Dec 25, 2012
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.